MedPath

The exploration of the differences between two surgical approaches in total hip arthroplasty, direct anterior minimal invasive surgery and Hardinge’s approach, in obese and non-obese hip osteoarthritic patients

Not Applicable
Completed
Conditions
Hip osteoarthritis
Musculoskeletal Diseases
Registration Number
ISRCTN15066737
Lead Sponsor
niversity of West Attica
Brief Summary

2020 Interim results article in https://dx.doi.org/10.4103/2542-3975.288781 Results for direct anterior approach–minimally invasive surgery in obese and non-obese patients (added 03/09/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34888148/ (added 13/12/2021)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
120
Inclusion Criteria

1. Age >50 years
2. Symptomatic and radiographically con?rmed hip OA
3. All participants must be ambulatory before surgery
4. Willing to be assigned to the study

Exclusion Criteria

1. Dementia, chronic respiratory disease, chronic renal failure, heart failure, neurological disorder, undergoing chemotherapy, and previous osteotomy or arthroscopy to the involved hip
2. In addition, after enrolment, patients will be excluded if they present postoperative complications that might prevent them from receiving the standardized postoperative physiotherapy intervention

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Measured preoperatively (baseline), at the end of the 4th and 8th postoperative week:<br>1. Pain levels evaluated using the Face Pain Scale-Revised (FPS-R)<br>2. Functionality measured with the Greek version of the Modified Harris Hip Score (MHHS-Gr) and the Timed Up and Go (TUG) test<br>3. Quality of life evaluated using the Greek version of the International Hip Outcome Tool-12 items (i-HOT12-Gr)
Secondary Outcome Measures
NameTimeMethod
There are no secondary outcome measures
© Copyright 2025. All Rights Reserved by MedPath